{{Motif
|accession=000014
|aglycon=Ser/Thr
|alignment=Whole-Glycan
|collection=GGM
|displayhgv=false
|glycoct=RES
1b:a-dgal-HEX-1:5
2s:n-acetyl
3b:b-dgal-HEX-1:5
4b:a-dgro-dgal-NON-2:6{{!}}1:a{{!}}2:keto{{!}}3:d
5s:n-acetyl
6b:a-dgro-dgal-NON-2:6{{!}}1:a{{!}}2:keto{{!}}3:d
7s:n-acetyl
LIN
1:1d(2+1)2n
2:1o(3+1)3d
3:3o(3+2)4d
4:4d(5+1)5n
5:1o(6+2)6d
6:6d(5+1)7n
|glytoucan=G01614ZM
|name=Di-sialyl T antigen
|prefname=Di-sialyl T antigen
|redend=true
|reference=Cummings (2009) The repertoire of glycan determinants in the human glycome;Vyas et al. (2005) Potent glycan inhibitors of myelin-associated glycoprotein enhance axon outgrowth in ...;Macauley et al. (2014) Siglec-mediated regulation of immune cell function in ...
|sameas=GD.R000282,GDB.002360,GDC.000014,GDV.000092,GE.EP0023,GM.G01614ZM,UCM.000048
|wurcs=WURCS{{=}}2.0/3,4,3/{{!(}}a2112h-1a_1-5_2*NCC/3{{=}}O{{!)}}{{!(}}a2112h-1b_1-5{{!)}}{{!(}}Aad21122h-2a_2-6_5*NCC/3{{=}}O{{!)}}/1-2-3-3/a3-b1_a6-d2_b3-c2
}}
